HAO

Haoxi Health Technology Limited (HAO) SWOT Analysis Analysis (2026)

Invetso Score: 3.6/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Strengths

Score: 4.2 (Moderate)

Current ratio and quick ratio of 3.45 indicate ample short-term liquidity, which is stronger than many leveraged peers and supports operating flexibility.

Debt-to-equity of 0.10 suggests a comparatively light equity leverage profile, reducing balance-sheet fragility versus more indebted competitors.

Cash conversion cycle of 8.3 days is efficient, implying faster working-capital turnover than peers and helping preserve liquidity through the cycle.

Weaknesses

Score:

ROIC of -43.0% signals value destruction, placing HAO well below profitable peers and indicating the business is not yet converting capital into returns.

Net debt to EBITDA of 4.25 is elevated versus stronger peers, limiting financial flexibility and increasing sensitivity to earnings volatility.

Missing margin disclosure alongside negative ROIC suggests weak operating economics relative to peers, constraining evidence of durable competitive positioning.

Opportunities

Score:

If management improves capital efficiency, the low leverage base could support faster earnings recovery than highly indebted peers with less balance-sheet room.

Efficient working-capital management creates room to scale revenue without proportional cash strain, which can improve peer-relative resilience as demand normalizes.

Any margin expansion would have an outsized effect from the current low-return base, allowing HAO to narrow the gap with better-performing peers.

Threats

Score:

Persistently negative ROIC raises the risk that peers with positive returns will compound faster, widening the structural performance gap over time.

High net debt to EBITDA leaves HAO more exposed than low-leverage peers if rates stay elevated or earnings weaken, pressuring valuation and flexibility.

Without visible margin data, peers with clearer cost advantages may sustain superior economics, making HAO vulnerable to competitive displacement.

Overall Score

Score:

HAO’s balance-sheet liquidity is a relative strength, but negative capital returns and elevated leverage leave its structural positioning weaker than most peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Haoxi Health Technology Limited. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →